Kala Pharmaceuticals

$7.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.46 (-6.03%) As of 6:09 PM UTC today

Why Robinhood?

You can buy or sell KALA and other stocks, options, and ETFs commission-free!

About KALA

Kala Pharmaceuticals, Inc. Common Stock, also called Kala Pharmaceuticals, is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA. The listed name for KALA is Kala Pharmaceuticals, Inc. Common Stock.

CEO
Mark T. Iwicki
Employees
136
Headquarters
Watertown, Massachusetts
Founded
2009
Market Cap
436.27M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.66M
High Today
$7.61
Low Today
$7.03
Open Price
$7.43
Volume
1.42M
52 Week High
$14.68
52 Week Low
$5.04

KALA Earnings

-$0.73
-$0.62
-$0.52
-$0.41
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.46 per share
Actual
-$0.55 per share
Replay Earnings Call

You May Also Like

SJB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure